Profile data is unavailable for this security.
About the company
Financiere de Tubize SA is a Belgium-based holding company. The Company holds minor capital in UCB SA. UCB is a Belgian pharmaceutical and specialty chemical company that specializes in two therapeutic areas: diseases of the central nervous system (CNS) and immunology. UCB, together with its subsidiaries, has research and development facilities in Belgium, Germany, Japan, the United Kingdom and the United States. The Company promotes the development of a sustainable biopharma ecosystem in Belgium and possibly in other geographic areas relevant to UCB.
- Revenue in EUR (TTM)0.00
- Net income in EUR92.74m
- Incorporated1928
- Employees--
- LocationFinanciere de Tubize SAAllee de la Recherche, 60BRUXELLES 1070BelgiumBEL
- Phone+32 476490844
- Websitehttps://www.financiere-tubize.be/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Zydus Lifesciences Ltd | 2.30bn | 462.55m | 8.56bn | 27.92k | 18.51 | 3.60 | 15.23 | 3.72 | 48.90 | 48.89 | 243.42 | 251.51 | 0.6253 | 1.60 | 5.09 | 8,773,830.00 | 12.70 | 10.92 | 17.02 | 16.35 | 72.40 | 63.12 | 20.30 | 16.73 | 1.44 | -- | 0.2554 | 17.81 | 18.90 | 10.27 | 17.96 | 30.92 | 13.63 | 25.74 |
| Biomarin Pharmaceutical Inc | 2.63bn | 441.89m | 9.32bn | 3.04k | 21.42 | 1.81 | 18.20 | 3.55 | 2.67 | 2.67 | 15.82 | 31.53 | 0.4278 | 0.4512 | 3.95 | 1,017,764.00 | 7.20 | 2.18 | 8.04 | 2.46 | 81.32 | 76.43 | 16.82 | 6.07 | 3.10 | -- | 0.0897 | 0.00 | 17.97 | 10.86 | 154.62 | -- | -9.83 | -- |
| Lupin Ltd | 2.33bn | 406.57m | 9.53bn | 19.98k | 23.49 | 5.16 | 18.01 | 4.10 | 94.43 | 94.43 | 540.38 | 429.82 | 0.8393 | 1.25 | 4.34 | 12,388,350.00 | 14.74 | 4.53 | 21.74 | 7.16 | 71.70 | 59.70 | 17.57 | 5.95 | 1.32 | 110.56 | 0.2396 | 29.13 | 13.48 | 8.11 | 71.41 | -- | 20.11 | 14.87 |
| Avidity Biosciences Inc | 17.72m | -466.83m | 9.57bn | 391.00 | -- | 5.67 | -- | 539.97 | -4.17 | -4.17 | 0.1589 | 12.85 | 0.0111 | -- | 2.78 | 53,370.84 | -29.13 | -30.46 | -31.29 | -33.14 | -- | -- | -2,634.59 | -1,901.74 | -- | -- | 0.00 | -- | 13.99 | 36.27 | -51.87 | -- | 97.52 | -- |
| Dr Reddy's Laboratories Ltd | 3.26bn | 523.50m | 9.74bn | 26.94k | 18.63 | -- | 13.86 | 2.99 | 66.81 | 66.81 | 416.15 | -- | -- | -- | -- | 12,871,960.00 | -- | 12.15 | -- | 16.94 | 65.76 | 66.18 | 15.92 | 15.81 | -- | 19.79 | -- | 14.69 | 16.54 | 13.26 | 1.38 | 22.84 | 41.26 | 9.86 |
| Recordati Industria Chmc Frmctc SpA | 2.55bn | 404.39m | 10.04bn | 4.58k | 24.45 | 5.09 | 16.38 | 3.93 | 1.96 | 1.96 | 12.40 | 9.42 | 0.5377 | 1.81 | 4.87 | 557,416.80 | 8.51 | 10.50 | 10.71 | 13.46 | 67.66 | 69.89 | 15.83 | 19.98 | 1.16 | 8.30 | 0.5651 | 36.98 | 12.45 | 9.58 | 7.01 | 2.46 | 13.94 | 4.90 |
| Financiere de Tubize SA | 0.00 | 92.74m | 10.10bn | -- | 108.95 | 5.22 | 108.95 | -- | 2.08 | 2.08 | 0.00 | 43.49 | 0.00 | -- | -- | -- | 4.81 | 5.68 | 4.85 | 5.89 | -- | -- | -- | 230.34 | -- | -- | 0.00 | 30.18 | -- | -- | 2.22 | -20.50 | -- | 10.90 |
| Cipla Ltd | 2.67bn | 427.42m | 10.13bn | 30.31k | 23.70 | -- | 19.34 | 3.80 | 56.26 | 56.26 | 350.81 | -- | -- | -- | -- | 9,352,779.00 | -- | 11.89 | -- | 14.49 | 66.53 | 59.55 | 16.03 | 14.74 | -- | 96.40 | -- | 22.40 | 6.88 | 9.97 | 27.93 | 27.80 | 9.14 | 34.08 |
| Orion Oyj | 1.63bn | 313.30m | 10.22bn | 4.03k | 32.54 | 10.02 | 28.16 | 6.28 | 2.23 | 2.23 | 11.59 | 7.24 | 0.9707 | 1.55 | 6.55 | 419,768.00 | 18.66 | 20.14 | 26.08 | 24.67 | 59.66 | 59.72 | 19.22 | 21.16 | 1.19 | 101.62 | 0.234 | 84.25 | 29.65 | 7.97 | 52.17 | 10.48 | 19.14 | 1.80 |
| Elanco Animal Health Inc | 3.90bn | 30.57m | 10.26bn | 9.00k | 339.43 | 1.79 | 17.11 | 2.63 | 0.0716 | 0.0716 | 9.23 | 13.58 | 0.3422 | 1.24 | 5.30 | 510,111.10 | 0.2683 | -2.71 | 0.2993 | -3.02 | 54.96 | 54.72 | 0.7841 | -9.52 | 1.23 | 1.30 | 0.3735 | -- | 0.4981 | 7.65 | 127.46 | 37.85 | -3.99 | -- |
| BridgeBio Pharma Inc | 300.40m | -676.84m | 10.43bn | 725.00 | -- | -- | -- | 34.71 | -4.19 | -4.19 | 1.86 | -10.03 | 0.4254 | -- | -- | 487,972.40 | -96.88 | -75.74 | -125.35 | -94.24 | 95.78 | 96.67 | -227.74 | -716.92 | 3.76 | -2.89 | 3.52 | -- | 2,285.27 | 40.48 | 16.70 | -- | 11.63 | -- |
| Ipsen SA | 3.76bn | 447.90m | 11.37bn | 5.36k | 25.27 | 2.65 | 13.24 | 3.02 | 5.37 | 5.37 | 45.07 | 51.13 | 0.5621 | 2.38 | 5.13 | 701,717.10 | 6.74 | 10.34 | 8.76 | 13.96 | 83.32 | 82.89 | 11.99 | 17.79 | 1.80 | 130.37 | 0.1704 | 16.95 | 8.11 | 5.83 | -42.33 | -- | 22.77 | 6.96 |
| Neurocrine Biosciences Inc | 2.28bn | 363.42m | 11.68bn | 1.80k | 32.93 | 4.58 | 30.05 | 5.13 | 4.19 | 4.19 | 26.25 | 30.13 | 0.6878 | 0.7611 | 4.44 | 1,490,389.00 | 10.97 | 10.41 | 12.71 | 12.71 | 98.37 | 98.47 | 15.95 | 15.71 | 3.27 | -- | 0.00 | -- | 24.81 | 24.48 | 36.68 | 55.94 | 20.97 | -- |
Data as of Feb 06 2026. Currency figures normalised to Financiere de Tubize SA's reporting currency: Euro EUR
5.60%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 07 Jan 2026 | 748.70k | 1.68% |
| Norges Bank Investment Managementas of 30 Jun 2025 | 355.46k | 0.80% |
| BlackRock Fund Advisorsas of 09 Jan 2026 | 325.98k | 0.73% |
| Fidelity Management & Research Co. LLCas of 30 Nov 2025 | 257.11k | 0.58% |
| Geode Capital Management LLCas of 29 Jan 2026 | 210.06k | 0.47% |
| BlackRock Advisors (UK) Ltd.as of 09 Jan 2026 | 198.81k | 0.45% |
| Amundi Asset Management SASU (Investment Management)as of 27 Jan 2026 | 143.15k | 0.32% |
| BNP Paribas Asset Management Europe SASas of 06 Jan 2026 | 107.74k | 0.24% |
| JPMorgan Asset Management (UK) Ltd.as of 31 Dec 2025 | 82.94k | 0.19% |
| Degroof Petercam Asset Management SAas of 30 Sep 2025 | 64.00k | 0.14% |
More ▼
Data from 30 Jun 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
